智通财经网·2025-08-26 12:37Core Viewpoint - Zhaoyan New Drug (06127) announced that it has received a total of RMB 28.85 million in various government subsidies from January 1, 2025, to the date of this announcement, with the data being unaudited [1] Summary by Category - Government Subsidies Received - The company received a total of RMB 28.85 million in government subsidies [1] - Among these, subsidies related to income amounted to RMB 14.48 million, accounting for 19.55% of the company's audited net profit attributable to equity shareholders for the most recent fiscal year [1] - Asset-related government subsidies totaled RMB 14.37 million, representing 0.18% of the company's audited net assets attributable to equity shareholders for the most recent fiscal year [1]